Opens in a new tab

Advanced Brain Monitoring v Koninklijke Philips (CoA, 22 July 2026)

Date22 July 2026
CourtCoA
DivisionLuxembourg (LU)
Type of actionAppeal
Case number(s)UPC_CoA_63/2026
Registry referenceUPC-COA-0000063/2026
PartiesAdvanced Brain Monitoring, Inc. v. Koninklijke Philips N.V., Philips RS North America LLC, Respironics Deutschland GmbH & Co. KG

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 22 July 2026, issued in the joined appeals UPC_CoA_63/2026 and UPC_CoA_64/2026, the judge-rapporteur of the Court of Appeal declined to rule in advance on the admissibility of eleven new auxiliary requests filed by Advanced Brain Monitoring with its statement of grounds of appeal. The respondents, Koninklijke Philips, Philips RS North America and Respironics Deutschland, must respond within the ordinary time limit, on admissibility and on the merits alike. The order confirms that the admissibility of new matter on appeal is, as a rule, decided together with the appeal itself.

Question

Should objections to the admissibility of auxiliary requests first filed on appeal be decided before the statement of response, and can the time limit for that statement run from such a decision?

Decision

The Hague Local Division had dismissed the infringement action and revoked EP 2 437 696 on 3 March 2026. The admissibility of the new requests depends on the circumstances of the appeal, including why they were first filed on appeal and whether they could reasonably have been filed earlier, and is better assessed at a later stage (paragraphs 10 to 12). Absent exceptional circumstances, which were not shown, such questions are decided with the appeal as a whole (paragraphs 13 to 15). The respondents know the content of the requests and can address them in their statement of response. A separate admissibility phase would not serve efficiency (paragraphs 16 to 18). The objections were reserved and the request for a three-month time limit running from an admissibility decision was rejected (paragraph 19).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 73(4)
Rules of Procedure
Rule 222.2

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.

Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CoA_63/2026 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Appeal
Outcome (Dhenne Avocats summary)
Le juge rapporteur de la cour d'appel réserve à un stade ultérieur les objections à la recevabilité des nouvelles requêtes subsidiaires et refuse de faire courir le délai du mémoire en réponse à compter d'une décision sur ce point.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 437 696 B2Mentioned in the analysis (role not qualified)
Also mentioned in 2 other decision(s): Advanced Brain Monitoring v Koninklijke Philips (CFI, 3 March 2026) · Advanced Brain Monitoring v Koninklijke Philips (CFI, 4 August 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.